Mendelian randomization identifies causal associations between GWAS-associated bacteria and their metabolites and rheumatoid arthritis
Frontiers in Microbiology · 02.09.2024 · 15
DOI: 10.3389/fmicb.2024.1431367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 02.09.2024. Verfasst von Donghai Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Accumulating evidence suggests that an imbalance of gut microbiota is commonly observed in patients with rheumatoid arthritis (RA). However, it remains unclear whether gut microbiota dysbiosis is a cause or consequence of RA, and the mechanisms by which gut dysbiosis contributes to RA have not been fully understood. This study aimed to investigate the causal relationship between gut microbiota and metabolites with RA.
Methods
A two-sample Mendelian randomization analysis was performed to estimate the causality of gut microbiota and metabolites on RA. A genome-wide association study (GWAS) of 211 gut microbiota and 217 metabolites was used as the exposure, whereas RA was treated as the outcome. Inverse variance weighted (IVW) was regarded as the primary approach for calculating causal estimates. MR Egger method, Weighted median method, Simple mode method, and weighted mode method were used for sensitive analysis. Metabolic pathway analysis was performed via the web-based Metaconflict 5.0. Additionally, an animal study was undertaken to evaluate the results inferred by Mendelian randomization.
Result
This study indicated that six gut microbiota taxa ( RuminococcaceaeUCG013, Erysipelotrichia, Erysipelotrichaceae, Erysipelotrichales, Clostridia , and Veillonellaceae ) were estimated to exert a positive impact on RA. Conversely, seven gut microbiota taxa ( Oxalobacter, Cyanobacteria, RuminococcaceaeUCG002, LachnospiraceaeUCG010, Christensenellaceae, Oxalobacteraceae, Anaerostipes ) were estimated to exert a negative impact on RA. Three metabolites, namely indole-3-propionate (IPA), glycine and sphingomyelin (SM 16:1), were found to be linked to lower RA risk, while five metabolites (argininosuccinate, CE 20_4, TAG 58_8, PC 40_6, and LPC 20_4) were linked to higher RA risk. Additionally, four metabolic pathways were identified by metabolic pathway analysis. The collagen-induced arthritis (CIA) rats exhibited a higher relative abundance of Class_Clostridia and a lower abundance of Genus_Lachnospiraceae ( p < 0.05) than the healthy controls.
Conclusion
This study identified causal associations between specific gut microbiota, metabolites, and RA. These findings support the significant role of gut microbiota and metabolites in RA pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- School of Basic Medicine, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China.
Zitieren
APA
Zhou, D., Jiao, W., Shi, W., Wang, Q., & Chen, M. (2024). Mendelian randomization identifies causal associations between GWAS-associated bacteria and their metabolites and rheumatoid arthritis. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1431367
Vancouver
Zhou D, Jiao W, Shi W, Wang Q, Chen M. Mendelian randomization identifies causal associations between GWAS-associated bacteria and their metabolites and rheumatoid arthritis. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1431367
BibTeX
@article{Zhou2024,
author = {Zhou, Donghai and Jiao, Wenyue and Shi, Weiman and Wang, Qiao and Chen, Muzhi},
title = {Mendelian randomization identifies causal associations between GWAS-associated bacteria and their metabolites and rheumatoid arthritis},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1431367}
}
EUVIMED